Big Buttons

• CALL TO ACTION: Tell FDA to deny drugmakers’ request

  Drugmakers are urging FDA to prohibit compounded GLP-1s. FDA needs to hear from you and your patients NOW! read more →

• APC to FDA: Just say no to Lilly

  This week APC's lawyers sent a formal comment to the FDA about Eli Lilly’s request that tirzepatide be added to the Demonstrably Difficult to Compound list. read more →

• California BOP sends proposed compounding regs to comment period

  The California State Board of Pharmacy decided to move the modified proposed sterile compounding regulations forward to a 30-day comment period. read more →

• Checking in on the post-Chevron fallout

  What’s happened in the world of federal regulation since the end of Chevron? read more →

• Hi, Noom!

  Welcome to our newest Bronze-level Corporate Patron, Noom! read more →

• PFMs can get 2.5% credit card processing

  A new benefit for APC’s Pharmacy/Facility Members: They may be able to cut their credit card processing fees to just 2.5% – 2.8%. read more →

• Phoenix compounders, rise!

  The latest of APC’s new regional meetings — CompoundED UpDATE — is coming to the Phoenix area December 5. read more →

• APC election results: directors and bylaws

  See the results of APC's elections, including four new directors and several changes to our bylaws. read more →

More News

Big news for APC Pharmacy-Facility Members: You now have access to a great new compounding-specific patient-reported outcomes tool: OutcomeMD.

It’s an outcome-tracking and marketing platform — an extraordinary strategic tool for the compounding profession and a great business solution for individual pharmacies.

Why it matters

There’s plenty of anecdotal evidence for positive patient outcomes, but not enough of the validated, standardized data FDA wants to see. The OutcomeMD platform will help change that, allowing APC to aggregate patient-reported outcome data while providing compounding pharmacy owners granular data on how their formulations are working for patients.

“The OutcomeMD platform is something long-needed in compounding: A means of collecting and aggregating patient outcomes data in a way that’s not just useful to the pharmacy but useful to the profession,” said APC’s CEO Scott Brunner, CAE.

Via a smartphone app, patients respond to questions about how their specific therapies are working. Owners in turn get data about those formulations using the same validated measures used in clinical trials (and that FDA uses in its database). And, with the owners’ permission, APC gets access to the aggregated metadata — scrubbed of HIPAA-protected details, of course — to share with FDA and demonstrate how patients benefit from compounded therapies.

Benefits to your pharmacy

Using OutcomeMD also provides direct benefits to you and your patients.

• You’ll have more information about your formulations, allowing you to make adjustments that benefit patients — and to market your services to prescribers.
• Patients will appreciate the improved customer service; it’s easier for your team to monitor their progress and respond more quickly to questions or concerns.
• By highlighting success stories, OutcomeMD provides you a powerful marketing tool — it even creates graphics to share on social media and helps patients share their success on review sites.

Thanks to our partnership with OutcomeMD, APC Pharmacy/Facility Members members receive more than half off OutcomeMD’s standard subscription rates.

Get started

Learn more about everything an OutcomeMD subscription provides at OutcomeMD.com.

Then reach out to Lorraine Kaiser at lkaiser@outcomemd.com to schedule your demo. You can even click here to schedule it directly.

Any questions? APC’s Jason Dunn — jason@a4pc.org or (918) 770-6333 — can help.